Prognostic value of pretreatment serum lactate dehydrogenase level in patients with solid tumors: a systematic review and meta-analysis

J Zhang, YH Yao, BG Li, Q Yang, PY Zhang… - Scientific reports, 2015 - nature.com
Although most studies have reported that high serum lactate dehydrogenase (LDH) levels
are associated with poor prognosis in several malignancies, the consistency and magnitude …

[HTML][HTML] British Thoracic Society Guideline for the investigation and management of malignant pleural mesothelioma

I Woolhouse, L Bishop, L Darlison, D De Fonseka… - Thorax, 2018 - thorax.bmj.com
Refer all patients with a chest X-ray suggestive of MPM urgently (via the 2-week wait
suspected cancer pathway in England and Wales). Consider referral for further investigation …

The role of imaging in malignant pleural mesothelioma: an update after the 2018 BTS guidelines

S Sinha, AJ Swift, MA Kamil, S Matthews, MJ Bull… - Clinical Radiology, 2020 - Elsevier
Malignant pleural mesothelioma (MPM) is a primary malignancy of the pleura and is
associated with a poor outcome. The symptoms and signs of malignant mesothelioma …

[HTML][HTML] Supplementary prognostic variables for pleural mesothelioma: a report from the IASLC staging committee

HI Pass, D Giroux, C Kennedy, E Ruffini… - Journal of Thoracic …, 2014 - Elsevier
Introduction: The staging system for malignant pleural mesothelioma is controversial. To
revise this system, the International Association for the Study of Lung Cancer Staging …

Prognostic nutritional index predicts outcomes of malignant pleural mesothelioma

ZH Yao, GY Tian, YY Wan, YM Kang, HS Guo… - Journal of cancer …, 2013 - Springer
Purpose Nutritional status has been associated with long-time outcomes in cancer patients.
We investigated whether the prognostic nutritional index (PNI), an indicator of nutritional …

Prognostic factors influencing survival in 35 patients with malignant peritoneal mesothelioma.

H Kaya, C Sezgı, AC Tanrıkulu, M Taylan, O Abakay… - Neoplasma, 2014 - europepmc.org
Malignant mesothelioma is a rare but highly lethal form of cancer that affects the serosal
membranes. Malignant peritoneal mesothelioma (MPM) is the second most common form of …

KRAS signaling in malignant pleural mesothelioma

A Marazioti, AC Krontira, SJ Behrend… - EMBO Molecular …, 2022 - embopress.org
Malignant pleural mesothelioma (MPM) arises from mesothelial cells lining the pleural cavity
of asbestos‐exposed individuals and rapidly leads to death. MPM harbors loss‐of‐function …

Myeloid-derived interleukin-1β drives oncogenic KRAS-NF-κΒ addiction in malignant pleural effusion

A Marazioti, I Lilis, M Vreka, H Apostolopoulou… - Nature …, 2018 - nature.com
Malignant pleural effusion (MPE) is a frequent metastatic manifestation of human cancers.
While we previously identified KRAS mutations as molecular culprits of MPE formation, the …

Pretreatment serum C-reactive protein levels predict benefit from multimodality treatment including radical surgery in malignant pleural mesothelioma: a retrospective …

B Ghanim, MA Hoda, MP Winter, T Klikovits… - Annals of …, 2012 - journals.lww.com
Objective: To evaluate the prognostic and predictive relevance of pretreatment serum C-
reactive protein (CRP) in malignant pleural mesothelioma (MPM) patients. Background …

Ki67 index is an independent prognostic factor in epithelioid but not in non-epithelioid malignant pleural mesothelioma: a multicenter study

B Ghanim, T Klikovits, MA Hoda, G Lang… - British journal of …, 2015 - nature.com
Background: Estimating the prognosis in malignant pleural mesothelioma (MPM) remains
challenging. Thus, the prognostic relevance of Ki67 was studied in MPM. Methods: Ki67 …